Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody … – KKCO,

HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021. VISTA is a co-inhibitory immune checkpoint receptor that is involved in suppressing …, HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021. VISTA is a co-inhibitory immune checkpoint receptor that is involved in suppressing …, Read More

Scroll to Top